Salt, hypertension, and proteinuria in diabetic nephropathy

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 5, 2014, Pages 351-352

  Weir, Matthew R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; SODIUM CHLORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; THIAZIDE DIURETIC AGENT; DIURETIC AGENT;

CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; NOTE; PATIENT EDUCATION; PRIORITY JOURNAL; PROTEINURIA; RISK REDUCTION; SODIUM RESTRICTION; TREATMENT INDICATION; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SODIUM INTAKE; ALBUMINURIA; DIABETIC NEUROPATHIES; DRUG EFFECTS; FEMALE; MALE;

ALBUMINURIA; DIABETIC NEUROPATHIES; DIET, SODIUM-RESTRICTED; DIURETICS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; MALE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84899897336     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70213-4     Document Type: Note

References (7)

1. de Zeeuw D, Remuzzi G, Parving HH, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004, 65:2309-2320.
2. de Zeeuw D, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004, 110:921-927.
3. Eijkelkamp WB, Zhang Z, Remuzzi G, et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 2007, 18:1540-1546.
4. Holtkamp FA, de Zeeuw D, de Graeff PA, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011, 32:1493-1499.
5. Kwakernaak AJ, Krikken JA, Binnenmars SH, et al. Effects of sodium restriction and hydrochlorothiazide added to RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol 2014, published online March 5. http://dx.doi.org/10.1016/S2213-8587(14)70030-0.
6. Lambers Heerspink HJ, Holtkamp FA, Parving HH, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 2012, 82:330-337.
7. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008, 19:999-1007.